 | Acumen Pharmaceuticals, Inc. | |||
| NMS : ABOS || Location: United States | ||||
$3.18+0.02 (+0.63%) |
0.15 M | 3.11 - 3.2 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.239 M |
| Feb. 29, 2024 | 0.773 M |
| Feb. 15, 2024 | 0.680 M |
| Jan. 31, 2024 | 0.732 M |
| Jan. 12, 2024 | 0.699 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.27 | -0.28 | -5.58% |
| 09/30/2023 | -0.27 | -0.24 | 11.54% |
| 06/30/2023 | -0.35 | -0.28 | 20.66% |
| 03/31/2023 | -0.35 | -0.28 | 20.66% |
| 12/31/2022 | -0.26 | -0.32 | -22.84% |
ABOS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 60.080M | Shares Float | 32.280M |
| Short Float | 1.239M | Market Cap | 189.85M |
| Institution ownership | 72.62% | Insider ownership | 9.126% |
| Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.08 | Forward EPS | -1.40 |